The FDA is introducing a new priority voucher program designed to shorten the drug review process from 10 to 12 months down to one or two months, according to the agency. The federal outfit's "Commissioner's National Priority Voucher" (CNPV) program will include a "limited number of vouchers" for "companies aligned with U.S. national priorities," according to a June 17 press release.
The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions align with the agency's national health priorities. www.statnews.com/2025/06/17/f ...
-- STAT (@statnews.com) Jun 17, 2025 at 12:15 PM
[image or embed]
Drudge Retort Headlines
Minutes Show Fed Divided over Tariff-driven Inflation (56 comments)
Trump's Polls Lower Than Any Other Modern President (35 comments)
Start Budgeting Now (27 comments)
Canada Gets 35% Tariff (21 comments)
Trump Threatens to Revoke Rosie O'Donnell's US Citizenship (16 comments)
Trump Praises Liberian President's 'Good English' (15 comments)
Earth's Rotation Is Picking Up Speed (15 comments)
Fuel Switches Cut Off Before Air India Crash (14 comments)
Trump Tours Texas Flood Sites and Defends Officials (13 comments)
Trump: Defund PBS, NPR - Or Lose My Endorsement (13 comments)